No Data
Maxim Group Maintains Azitra(AZTR.US) With Buy Rating, Maintains Target Price $3
Azitra Inc (AZTR) Receives a Buy From Maxim Group
Express News | Azitra Shares Are Trading Higher After the Company Received FDA Approval to Proceed With Its Phase 1/2 Clinical Study of ATR-04
Azitra Receives Study May Proceed Letter From The FDA For IND To Treat Skin Rash From EGFR Inhibitors
Express News | Azitra Inc - Preclinical Data Show Atr-04 Reduces Il-36Γ and Staphylococcus Aureus
Express News | Azitra Receives Study May Proceed Letter From the FDA for Ind to Treat Skin Rash From Egfr Inhibitors
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
